Study details
Enrolling now
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
The Methodist Hospital Research Institute
NCT IDNCT07050771ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
18+
Locations
1 site in TX
What this study is about
This Phase 2 study is focused on people with bladder cancer. The primary outcome being measured is Rates of adverse events and serious adverse events.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Rates of adverse events and serious adverse events
Secondary: Disease-free survival (DFS), Health-related quality of life (HRQOL), Overall survival (OS), Postoperative length of stay
Body systems
Oncology, Renal